CIBC Bancorp USA’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
CIBC Bancorp USA's LLY Position: Q2 2026 in Review
CIBC Bancorp USA increased its Eli Lilly (LLY) stake by 0.2% in Q2 2026, buying an estimated $1.86M and bringing the position to 906,485 shares worth $1.09B. The position accounts for 1.32% of the portfolio, ranked #10.
CIBC Bancorp USA first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- CIBC Bancorp USA held 906,485 shares of Eli Lilly worth $1.09B as of Q2 2026.
- CIBC Bancorp USA bought 1,825 Eli Lilly shares in Q2 2026, an estimated $1.86M.
- Eli Lilly made up 1.32% of CIBC Bancorp USA's portfolio in Q2 2026, its #10 holding.
- CIBC Bancorp USA first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
- 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.